CONNAUGHT SQUARE PRACTICE
41 CONNAUGHT SQUARE, LONDON
CKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 1 | 1 | 100.0% | |
| CKD 4 | 2008 | 0 | 0 | NA% | |
| CKD 5 | 2009 | 0 | 0 | NA% | |
| CKD 5 | 2010 | 1 | 1 | 100.0% | |
| CKD 5 | 2011 | 1 | 1 | 100.0% | |
| CKD 5 | 2012 | 4 | 4 | 100.0% | |
| CKD 5 | 2013 | 9 | 10 | 90.0% | |
| CKD003 | 2014 | 9 | 9 | 100.0% | |
| CKD003 | 2015 | 6 | 7 | 85.7% | |
| NM84 | 2016 | 7 | 11 | 63.6% | |
| NM84 | 2017 | 12 | 15 | 80.0% | |
| NM84 | 2018 | 11 | 16 | 68.8% | |
| NM84 | 2020 | 12 | 21 | 57.1% | |
| NM84 | 2022 | 24 | 37 | 64.9% | |
| NM84 | 2023 | 26 | 36 | 72.2% |
